| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.06e-05 | 187 | 112 | 8 | GO:0016922 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 1.61e-05 | 143 | 112 | 7 | GO:0017124 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | TCF7L2 NR4A3 CC2D1A BCL11A NR4A1 RREB1 ZNF865 FOXP4 BCL11B ZFHX4 NFATC4 EGR3 ZNF358 ZNF746 ZFHX2 SIX5 GLIS1 FOXP3 | 1.88e-04 | 1244 | 112 | 18 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | TCF7L2 NR4A3 CC2D1A BCL11A NR4A1 RREB1 ZNF865 FOXP4 BCL11B ZFHX4 NFATC4 EGR3 ZNF358 ZNF746 ZFHX2 SIX5 GLIS1 FOXP3 | 2.44e-04 | 1271 | 112 | 18 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | TCF7L2 DBX2 SHOX NR4A3 CC2D1A BCL11A NR4A1 RREB1 FOXP4 BCL11B ZFHX4 NFATC4 EGR3 ZNF358 ZNF746 ZFHX2 SIX5 GLIS1 FOXP3 | 3.08e-04 | 1412 | 112 | 19 | GO:0000981 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | TCF7L2 SHOX NR4A3 NR4A1 RREB1 BCL11B EGR3 ZNF358 SIX5 GLIS1 FOXP3 | 3.11e-04 | 560 | 112 | 11 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | TCF7L2 SHOX NR4A3 NR4A1 RREB1 BCL11B EGR3 ZNF358 SIX5 GLIS1 FOXP3 | 3.41e-04 | 566 | 112 | 11 | GO:0001216 |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase kinase activity | 4.61e-04 | 6 | 112 | 2 | GO:0008349 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP32 PSD WAS TRIO RGL3 RAP1GAP2 ARHGAP17 RGS20 SIPA1L1 ARHGEF26 | 5.70e-04 | 507 | 112 | 10 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP32 PSD WAS TRIO RGL3 RAP1GAP2 ARHGAP17 RGS20 SIPA1L1 ARHGEF26 | 5.70e-04 | 507 | 112 | 10 | GO:0030695 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 5.72e-04 | 417 | 112 | 9 | GO:0061629 | |
| GeneOntologyMolecularFunction | transcription factor binding | TCF7L2 NACA NR4A3 BCL11A NR4A1 TGFB1I1 PPARGC1A BAZ2A NFATC4 MED25 CNOT1 FOXP3 | 1.06e-03 | 753 | 112 | 12 | GO:0008134 |
| GeneOntologyMolecularFunction | armadillo repeat domain binding | 1.09e-03 | 9 | 112 | 2 | GO:0070016 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | TCF7L2 NR4A3 CC2D1A BCL11A NR4A1 RREB1 ZNF865 FOXP4 BCL11B ZFHX4 NFATC4 EGR3 ZNF358 ZNF746 ZFHX2 SIX5 GLIS1 FOXP3 | 1.24e-03 | 1459 | 112 | 18 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | TCF7L2 NR4A3 BCL11A NR4A1 TGFB1I1 PPARGC1A BAZ2A MED25 CNOT1 FOXP3 | 1.62e-03 | 582 | 112 | 10 | GO:0140297 |
| GeneOntologyMolecularFunction | scaffold protein binding | 1.87e-03 | 93 | 112 | 4 | GO:0097110 | |
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 1.98e-03 | 12 | 112 | 2 | GO:0015279 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 2.19e-03 | 320 | 112 | 7 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 2.43e-03 | 326 | 112 | 7 | GO:0001217 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 2.72e-03 | 14 | 112 | 2 | GO:0070679 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | SHANK1 CACNA1A ARHGAP32 ZFYVE27 MAP1A TRIO TRPC5 NR4A3 CC2D1A BCL11A RREB1 TTC3 SHROOM2 BCL11B NFATC4 SIPA1L1 SH3D19 ARHGEF26 MAP2K2 CAP1 | 6.98e-06 | 1194 | 113 | 20 | GO:0000902 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | SHANK1 CACNA1A ARHGAP32 ZFYVE27 MAP1A TRIO TRPC5 NR4A3 CC2D1A BCL11A RREB1 TTC3 BCL11B NFATC4 SIPA1L1 MAP2K2 | 9.99e-06 | 819 | 113 | 16 | GO:0120039 |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 1.08e-05 | 192 | 113 | 8 | GO:0050770 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | SHANK1 CACNA1A ARHGAP32 ZFYVE27 MAP1A TRIO TRPC5 NR4A3 CC2D1A BCL11A RREB1 TTC3 BCL11B NFATC4 SIPA1L1 MAP2K2 | 1.11e-05 | 826 | 113 | 16 | GO:0048858 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | SHANK1 CACNA1A ARHGAP32 ZFYVE27 MAP1A TRIO TRPC5 NR4A3 CC2D1A BCL11A TTC3 BCL11B NFATC4 SIPA1L1 MAP2K2 | 1.43e-05 | 748 | 113 | 15 | GO:0048667 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | SHANK1 CACNA1A ARHGAP32 ZFYVE27 MAP1A TRIO TRPC5 NR4A3 CC2D1A BCL11A TTC3 BCL11B NFATC4 SIPA1L1 MAP2K2 | 3.21e-05 | 802 | 113 | 15 | GO:0048812 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TCF7L2 WAS NACA SHOX NR4A3 SUPT20HL2 POGZ NR4A1 RREB1 PPARGC1A BCL2L12 BCL11B NFATC4 EGR3 ATXN7 ZNF746 MED25 SIX5 GLIS1 FOXP3 | 6.18e-05 | 1390 | 113 | 20 | GO:0045944 |
| GeneOntologyBiologicalProcess | axonogenesis | CACNA1A ARHGAP32 ZFYVE27 MAP1A TRIO TRPC5 NR4A3 BCL11A TTC3 BCL11B SIPA1L1 MAP2K2 | 6.46e-05 | 566 | 113 | 12 | GO:0007409 |
| GeneOntologyBiologicalProcess | neuron projection development | SHANK1 CACNA1A ARHGAP32 ZFYVE27 PSD MAP1A TRIO CECR2 TRPC5 RAP1GAP2 NR4A3 CC2D1A BCL11A TTC3 BCL11B NFATC4 SIPA1L1 MAP2K2 TNXB | 6.75e-05 | 1285 | 113 | 19 | GO:0031175 |
| GeneOntologyCellularComponent | chromatin | SPHK2 TCF7L2 EP400 DBX2 CECR2 SHOX NR4A3 SUPT20HL2 POGZ BCL11A NR4A1 PPARGC1A FOXP4 BCL11B ZFHX4 BAZ2A NFATC4 EGR3 ATXN7 ZFHX2 ANKRD17 SIX5 DNTT FOXP3 | 1.17e-06 | 1480 | 114 | 24 | GO:0000785 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.82e-04 | 96 | 114 | 5 | GO:0070603 | |
| Domain | SH3 | 6.14e-06 | 216 | 112 | 9 | SM00326 | |
| Domain | SH3_domain | 7.13e-06 | 220 | 112 | 9 | IPR001452 | |
| Domain | Znf_C2H2-like | ZNF207 POGZ BCL11A RREB1 ZNF865 FOXP4 BCL11B ZFHX4 EGR3 ATXN7 ZNF358 ZNF746 ZFHX2 ZNF598 GLIS1 FOXP3 | 2.11e-05 | 796 | 112 | 16 | IPR015880 |
| Domain | Znf_C2H2 | ZNF207 POGZ BCL11A RREB1 ZNF865 FOXP4 BCL11B ZFHX4 EGR3 ATXN7 ZNF358 ZNF746 ZFHX2 ZNF598 GLIS1 FOXP3 | 2.42e-05 | 805 | 112 | 16 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF207 POGZ BCL11A RREB1 ZNF865 FOXP4 BCL11B ZFHX4 EGR3 ATXN7 ZNF358 ZNF746 ZFHX2 ZNF598 GLIS1 FOXP3 | 2.54e-05 | 808 | 112 | 16 | SM00355 |
| Domain | DUF4599 | 4.44e-05 | 12 | 112 | 3 | PF15371 | |
| Domain | DUF4599 | 4.44e-05 | 12 | 112 | 3 | IPR027970 | |
| Domain | SH3 | 4.77e-05 | 216 | 112 | 8 | PS50002 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF207 POGZ BCL11A RREB1 ZNF865 FOXP4 BCL11B ZFHX4 EGR3 ZNF358 ZNF746 ZFHX2 ZNF598 GLIS1 FOXP3 | 6.02e-05 | 775 | 112 | 15 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF207 POGZ BCL11A RREB1 ZNF865 FOXP4 BCL11B ZFHX4 EGR3 ZNF358 ZNF746 ZFHX2 ZNF598 GLIS1 FOXP3 | 6.20e-05 | 777 | 112 | 15 | PS00028 |
| Domain | hSH3 | 1.07e-04 | 3 | 112 | 2 | PF14603 | |
| Domain | Nuc_orph_rcpt | 1.07e-04 | 3 | 112 | 2 | IPR003070 | |
| Domain | hSH3 | 1.07e-04 | 3 | 112 | 2 | IPR029294 | |
| Domain | AT_hook | 1.11e-04 | 16 | 112 | 3 | PF02178 | |
| Domain | SCA7 | 2.12e-04 | 4 | 112 | 2 | PF08313 | |
| Domain | FOXP-CC | 2.12e-04 | 4 | 112 | 2 | PF16159 | |
| Domain | FOXP-CC | 2.12e-04 | 4 | 112 | 2 | IPR032354 | |
| Domain | CAS_DUF3513 | 2.12e-04 | 4 | 112 | 2 | IPR021901 | |
| Domain | SCA7_dom | 2.12e-04 | 4 | 112 | 2 | IPR013243 | |
| Domain | MAPKKKK | 2.12e-04 | 4 | 112 | 2 | IPR021160 | |
| Domain | DUF3513 | 2.12e-04 | 4 | 112 | 2 | PF12026 | |
| Domain | SCA7 | 2.12e-04 | 4 | 112 | 2 | PS51505 | |
| Domain | SH3_1 | 4.65e-04 | 164 | 112 | 6 | PF00018 | |
| Domain | TRP_2 | 5.26e-04 | 6 | 112 | 2 | PF08344 | |
| Domain | TRP_dom | 5.26e-04 | 6 | 112 | 2 | IPR013555 | |
| Domain | TRPC_channel | 7.34e-04 | 7 | 112 | 2 | IPR002153 | |
| Domain | HMGI/Y_DNA-bd_CS | 8.35e-04 | 31 | 112 | 3 | IPR000637 | |
| Domain | SH3_9 | 1.24e-03 | 78 | 112 | 4 | PF14604 | |
| Domain | Rap_GAP | 1.55e-03 | 10 | 112 | 2 | PF02145 | |
| Domain | TRP_channel | 1.89e-03 | 11 | 112 | 2 | IPR004729 | |
| Domain | Rap_GAP_dom | 1.89e-03 | 11 | 112 | 2 | IPR000331 | |
| Domain | RAPGAP | 1.89e-03 | 11 | 112 | 2 | PS50085 | |
| Domain | - | BCL11A RREB1 ZNF865 BCL11B ZFHX4 EGR3 ZNF358 ZNF746 ZFHX2 GLIS1 FOXP3 | 2.55e-03 | 679 | 112 | 11 | 3.30.160.60 |
| Domain | zf-C2H2 | POGZ BCL11A RREB1 ZNF865 BCL11B ZFHX4 EGR3 ZNF358 ZNF746 ZFHX2 GLIS1 | 2.98e-03 | 693 | 112 | 11 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | BCL11A RREB1 ZNF865 BCL11B ZFHX4 EGR3 ZNF358 ZNF746 ZFHX2 GLIS1 FOXP3 | 3.01e-03 | 694 | 112 | 11 | IPR013087 |
| Domain | CNH | 3.09e-03 | 14 | 112 | 2 | SM00036 | |
| Domain | CNH | 3.56e-03 | 15 | 112 | 2 | PF00780 | |
| Domain | CNH | 3.56e-03 | 15 | 112 | 2 | PS50219 | |
| Domain | CNH_dom | 3.56e-03 | 15 | 112 | 2 | IPR001180 | |
| Domain | Homeodomain-like | 3.88e-03 | 332 | 112 | 7 | IPR009057 | |
| Domain | Ion_trans_dom | 4.93e-03 | 114 | 112 | 4 | IPR005821 | |
| Domain | Ion_trans | 4.93e-03 | 114 | 112 | 4 | PF00520 | |
| Domain | Homeobox_CS | 5.28e-03 | 186 | 112 | 5 | IPR017970 | |
| Pubmed | ARHGAP32 TCF7L2 ATXN7L2 EP400 NACA FBRS CC2D1A POGZ BCL11A TNRC6C RREB1 POM121C CDCA2 PRR12 FOXP4 LARP4B ZFHX4 SUGP2 NFATC4 ATXN7 ZNF746 ANKRD17 SIX5 CNOT1 | 4.26e-11 | 1429 | 115 | 24 | 35140242 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SPHK2 SETD1B REPS1 EP400 TRIO FBRS RAP1GAP2 ARHGAP17 CC2D1A TNRC6C TTC3 POM121C ZNF865 PRR12 PHLDB1 CELSR1 SUGP2 SYNJ1 SCN8A MAPKBP1 | 6.19e-10 | 1105 | 115 | 20 | 35748872 |
| Pubmed | ERBB4 ATXN7L2 PSD EP400 MAP1A CECR2 FBRS POGZ BCL11A RREB1 POM121C FOXP4 LARP4B BCL11B ZFHX4 SUGP2 BAZ2A ATXN7 SIPA1L1 ANKRD17 | 7.34e-10 | 1116 | 115 | 20 | 31753913 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | TCF7L2 EP400 CECR2 FBRS POGZ RREB1 CDCA2 PRR12 FOXP4 BCL11B ZFHX4 SYNJ1 SIX5 | 8.09e-10 | 398 | 115 | 13 | 35016035 |
| Pubmed | SHANK1 ARHGAP32 SYNPO2 WAS MAP1A KIF26B RAP1GAP2 ARHGAP17 POGZ POM121C MAP4K5 SH3D19 ANKRD17 MAP2K2 | 8.84e-10 | 486 | 115 | 14 | 20936779 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ARHGAP32 ERBB4 SYNPO2 TCF7L2 EP400 MAP1A BCAR1 POM121C TGFB1I1 LARP4B NFATC4 MAP4K5 MAP4K1 | 2.06e-09 | 430 | 115 | 13 | 35044719 |
| Pubmed | Interaction network of human early embryonic transcription factors. | TCF7L2 EP400 FBRS POGZ BCL11A RREB1 POM121C PRR12 FOXP4 BCL11B ZFHX4 ZNF746 | 2.25e-09 | 351 | 115 | 12 | 38297188 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ARHGAP32 ERBB4 TRIO KIF26B ARHGAP17 CC2D1A BCAR1 CDCA2 PHLDB1 SYNJ1 MAP4K1 SIPA1L1 SH3D19 ANKRD17 ZNF598 MAP2K2 | 2.65e-08 | 861 | 115 | 16 | 36931259 |
| Pubmed | TCF7L2 ZNF207 NR4A3 POGZ BCL11A NR4A1 FOXP4 BCL11B BAZ2A NFATC4 ZNF358 ZNF746 ZFHX2 SIX5 | 1.01e-07 | 709 | 115 | 14 | 22988430 | |
| Pubmed | SETD1B EP400 RAP1GAP2 POGZ BCL11A TNRC6C PHLDB1 SUGP2 BAZ2A SIPA1L1 MAPKBP1 | 1.18e-07 | 407 | 115 | 11 | 12693553 | |
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 30089271 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 14525795 | ||
| Pubmed | Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis. | 1.41e-07 | 4 | 115 | 3 | 23334790 | |
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 33665581 | ||
| Pubmed | 2.47e-07 | 263 | 115 | 9 | 20932939 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EP400 POGZ TSSC4 RREB1 PALB2 SUGP2 BAZ2A ATXN7 MAP4K1 SIPA1L1 ANKRD17 MAP2K2 CCDC9 SF3B2 | 2.91e-07 | 774 | 115 | 14 | 15302935 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TCF7L2 DBX2 SHOX NR4A3 NR4A1 RREB1 FOXP4 BCL11B ZFHX4 NFATC4 EGR3 ZFHX2 SIX5 GLIS1 FOXP3 | 3.37e-07 | 908 | 115 | 15 | 19274049 |
| Pubmed | Suppression of Th2 and Tfh immune reactions by Nr4a receptors in mature T reg cells. | 3.50e-07 | 5 | 115 | 3 | 26304965 | |
| Pubmed | SHANK1 CACNA1A ARHGAP32 TRIO BCL11A TTC3 WDR91 DLGAP3 BCL11B SYNJ1 SIPA1L1 SH3D19 ANKRD17 ARHGEF26 CNOT1 | 7.05e-07 | 963 | 115 | 15 | 28671696 | |
| Pubmed | 1.59e-06 | 329 | 115 | 9 | 17474147 | ||
| Pubmed | 2.92e-06 | 9 | 115 | 3 | 28935710 | ||
| Pubmed | 4.90e-06 | 130 | 115 | 6 | 19386638 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | EP400 PAXX POGZ MRPS30 FOXP4 ZFHX4 SUGP2 NFATC4 ANKRD17 SIX5 ZNF598 SF3B2 FOXP3 | 5.46e-06 | 857 | 115 | 13 | 25609649 |
| Pubmed | SHANK1 CACNA1A ARHGAP32 ERBB4 MAP1A TRIO NACA SHROOM2 DLGAP3 LARP4B SUGP2 SYNJ1 SIPA1L1 CNOT1 CAP1 | 5.49e-06 | 1139 | 115 | 15 | 36417873 | |
| Pubmed | 5.83e-06 | 134 | 115 | 6 | 19030180 | ||
| Pubmed | The orphan nuclear receptor Nor1/Nr4a3 is a negative regulator of β-cell mass. | 1.08e-05 | 2 | 115 | 2 | 30696767 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 12196208 | ||
| Pubmed | NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes. | 1.08e-05 | 2 | 115 | 2 | 28249906 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 20668010 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 16891621 | ||
| Pubmed | The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms. | 1.08e-05 | 2 | 115 | 2 | 25410408 | |
| Pubmed | Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia. | 1.08e-05 | 2 | 115 | 2 | 17515897 | |
| Pubmed | Reduced NR4A gene dosage leads to mixed myelodysplastic/myeloproliferative neoplasms in mice. | 1.08e-05 | 2 | 115 | 2 | 21205929 | |
| Pubmed | CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis. | 1.08e-05 | 2 | 115 | 2 | 15465497 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 27496732 | ||
| Pubmed | PGC-1α ameliorates AngiotensinII-induced eNOS dysfunction in human aortic endothelial cells. | 1.08e-05 | 2 | 115 | 2 | 27235860 | |
| Pubmed | Pgc-1α and Nr4a1 Are Target Genes of Circadian Melatonin and Dopamine Release in Murine Retina. | 1.08e-05 | 2 | 115 | 2 | 26393668 | |
| Pubmed | PGC-1α dictates endothelial function through regulation of eNOS expression. | 1.08e-05 | 2 | 115 | 2 | 27910955 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 20411565 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 19153266 | ||
| Pubmed | A timer for analyzing temporally dynamic changes in transcription during differentiation in vivo. | 1.08e-05 | 2 | 115 | 2 | 29941474 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 25982469 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 31457080 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 31457081 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 23247046 | ||
| Pubmed | The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. | 1.08e-05 | 2 | 115 | 2 | 11719382 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 28795454 | ||
| Pubmed | GW182 proteins cause PABP dissociation from silenced miRNA targets in the absence of deadenylation. | 1.08e-05 | 2 | 115 | 2 | 23463101 | |
| Pubmed | Resistance of Foxp3+ regulatory T cells to Nur77-induced apoptosis promotes allograft survival. | 1.08e-05 | 2 | 115 | 2 | 18509529 | |
| Pubmed | 1.10e-05 | 418 | 115 | 9 | 34709266 | ||
| Pubmed | 1.31e-05 | 233 | 115 | 7 | 37704626 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | REPS1 EP400 MAP1A NACA CC2D1A POM121C SUGP2 SYNJ1 BAZ2A SH3D19 ANKRD17 ZNF598 SF3B2 | 1.36e-05 | 934 | 115 | 13 | 33916271 |
| Pubmed | REPS1 EP400 CC2D1A POGZ SUGP2 SYNJ1 BAZ2A SH3D19 ZNF598 CNOT1 | 1.50e-05 | 549 | 115 | 10 | 38280479 | |
| Pubmed | 2.45e-05 | 103 | 115 | 5 | 32744500 | ||
| Pubmed | 2.94e-05 | 107 | 115 | 5 | 30995489 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TCF7L2 TRIO TNRC6C BCAR1 TTC3 SHROOM2 FOXP4 PHLDB1 SUGP2 ATXN7 ZFHX2 ANKRD17 ARHGEF26 MAP2K2 CNOT1 GLIS1 | 3.23e-05 | 1489 | 115 | 16 | 28611215 |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 9038154 | ||
| Pubmed | NR4A nuclear receptors support memory enhancement by histone deacetylase inhibitors. | 3.24e-05 | 3 | 115 | 2 | 22996661 | |
| Pubmed | Inhibition of adipocyte differentiation by Nur77, Nurr1, and Nor1. | 3.24e-05 | 3 | 115 | 2 | 18945812 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 15647288 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 15964844 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 33462137 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 39178948 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 29343483 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 16020549 | ||
| Pubmed | Interaction between focal adhesion kinase and Crk-associated tyrosine kinase substrate p130Cas. | 3.24e-05 | 3 | 115 | 2 | 7479864 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 10523643 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 12223510 | ||
| Pubmed | Rapid and cost effective genotyping method for polymorphisms in PPARG, PPARGC1 and TCF7L2 genes. | 3.24e-05 | 3 | 115 | 2 | 18996470 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 20659174 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 29414782 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 36482877 | ||
| Pubmed | NR4A transcription factors limit CAR T cell function in solid tumours. | 3.24e-05 | 3 | 115 | 2 | 30814732 | |
| Pubmed | The NR4A orphan nuclear receptors: mediators in metabolism and diseases. | 3.24e-05 | 3 | 115 | 2 | 25089663 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 19465082 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 15910281 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 25899083 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 23552735 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 27159982 | ||
| Pubmed | The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss. | 3.24e-05 | 3 | 115 | 2 | 22143616 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 16873729 | ||
| Pubmed | The orphan nuclear receptor Nur77 is a determinant of myofiber size and muscle mass in mice. | 3.24e-05 | 3 | 115 | 2 | 25605333 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 28808448 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 32012348 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 24381004 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 25199433 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 24005216 | ||
| Pubmed | Deficiency of the NR4A orphan nuclear receptor NOR1 decreases monocyte adhesion and atherosclerosis. | 3.24e-05 | 3 | 115 | 2 | 20558821 | |
| Pubmed | Minireview: What is Known about SUMOylation Among NR4A Family Members? | 3.24e-05 | 3 | 115 | 2 | 34437889 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 24753204 | ||
| Pubmed | Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. | 3.24e-05 | 3 | 115 | 2 | 9155013 | |
| Pubmed | Differential regulation of Nr4a subfamily nuclear receptors following mast cell activation. | 3.24e-05 | 3 | 115 | 2 | 21621845 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 26634653 | ||
| Pubmed | Spontaneous food allergy in Was-/- mice occurs independent of FcεRI-mediated mast cell activation. | 3.24e-05 | 3 | 115 | 2 | 28600891 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 34001234 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 32323598 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 25917081 | ||
| Pubmed | FGF-8 stimulates the expression of NR4A orphan nuclear receptors in osteoblasts. | 3.24e-05 | 3 | 115 | 2 | 18809462 | |
| Pubmed | Regulation of pulmonary fibrosis by chemokine receptor CXCR3. | 3.24e-05 | 3 | 115 | 2 | 15254596 | |
| Pubmed | ARHGAP32 ATXN7L2 IFFO1 NR4A1 TGFB1I1 SUGP2 ATXN7 SIX5 MAPKBP1 PCBP4 | 3.57e-05 | 608 | 115 | 10 | 16713569 | |
| Interaction | EGR2 interactions | TCF7L2 EP400 FBRS POGZ BCL11A RREB1 PRR12 FOXP4 BCL11B ZFHX4 ZNF746 | 2.97e-09 | 171 | 112 | 11 | int:EGR2 |
| Interaction | FEV interactions | TCF7L2 EP400 FBRS POGZ BCL11A RREB1 PRR12 FOXP4 ZFHX4 ZNF746 SIX5 | 1.78e-08 | 203 | 112 | 11 | int:FEV |
| Interaction | SOX7 interactions | 1.79e-08 | 82 | 112 | 8 | int:SOX7 | |
| Interaction | GSC interactions | 5.49e-07 | 87 | 112 | 7 | int:GSC | |
| Interaction | TOP3B interactions | SPHK2 SETD1B REPS1 EP400 TRIO FBRS RAP1GAP2 ARHGAP17 CC2D1A TNRC6C TTC3 POM121C ZNF865 PRR12 LARP4B PHLDB1 CELSR1 SUGP2 SYNJ1 SCN8A ANKRD17 MAPKBP1 ZNF598 CNOT1 | 1.41e-06 | 1470 | 112 | 24 | int:TOP3B |
| Interaction | ELK3 interactions | 4.81e-06 | 120 | 112 | 7 | int:ELK3 | |
| Interaction | PAX7 interactions | 5.98e-06 | 124 | 112 | 7 | int:PAX7 | |
| Interaction | PAX6 interactions | TCF7L2 EP400 POLR3GL FBRS POGZ RREB1 TTC3 PRR12 ZFHX4 SYNJ1 ZNF746 | 6.23e-06 | 366 | 112 | 11 | int:PAX6 |
| Interaction | CRX interactions | 1.24e-05 | 254 | 112 | 9 | int:CRX | |
| Interaction | NCK2 interactions | 1.58e-05 | 262 | 112 | 9 | int:NCK2 | |
| Interaction | CNOT3 interactions | 2.06e-05 | 207 | 112 | 8 | int:CNOT3 | |
| Interaction | FYB1 interactions | 2.53e-05 | 31 | 112 | 4 | int:FYB1 | |
| Interaction | TBXT interactions | 4.65e-05 | 116 | 112 | 6 | int:TBXT | |
| Interaction | PTK2B interactions | 5.37e-05 | 119 | 112 | 6 | int:PTK2B | |
| Interaction | TLX1 interactions | 5.56e-05 | 175 | 112 | 7 | int:TLX1 | |
| Interaction | KLF8 interactions | 9.29e-05 | 329 | 112 | 9 | int:KLF8 | |
| Interaction | HELZ interactions | 9.51e-05 | 257 | 112 | 8 | int:HELZ | |
| Interaction | FOXL1 interactions | 1.13e-04 | 196 | 112 | 7 | int:FOXL1 | |
| Interaction | PHIP interactions | 1.17e-04 | 197 | 112 | 7 | int:PHIP | |
| Interaction | GRB2 interactions | ARHGAP32 ERBB4 REPS1 WAS MAP1A ARHGAP17 BCAR1 SHROOM2 SYNJ1 MAP4K5 MAP4K1 SH3D19 CNOT1 SF3B2 | 1.52e-04 | 806 | 112 | 14 | int:GRB2 |
| Interaction | FOXI1 interactions | 1.62e-04 | 92 | 112 | 5 | int:FOXI1 | |
| Interaction | MAGEA9 interactions | 1.64e-04 | 208 | 112 | 7 | int:MAGEA9 | |
| Interaction | CPEB1 interactions | 1.66e-04 | 146 | 112 | 6 | int:CPEB1 | |
| Interaction | NFIC interactions | 1.73e-04 | 210 | 112 | 7 | int:NFIC | |
| Interaction | KALRN interactions | 1.98e-04 | 96 | 112 | 5 | int:KALRN | |
| Interaction | CDK6 interactions | 2.00e-04 | 215 | 112 | 7 | int:CDK6 | |
| Interaction | ZC3H7A interactions | 2.00e-04 | 215 | 112 | 7 | int:ZC3H7A | |
| Interaction | KDM1A interactions | EP400 FPGS FBRS POGZ RREB1 PALB2 PRR12 ZFHX4 SYNJ1 SH3D19 ANKRD17 ZNF598 CNOT1 SF3B2 FOXP3 | 2.22e-04 | 941 | 112 | 15 | int:KDM1A |
| Interaction | CPEB4 interactions | 2.38e-04 | 156 | 112 | 6 | int:CPEB4 | |
| Interaction | VASP interactions | 2.39e-04 | 294 | 112 | 8 | int:VASP | |
| Interaction | MEX3B interactions | 2.44e-04 | 222 | 112 | 7 | int:MEX3B | |
| Interaction | LCP2 interactions | 2.48e-04 | 55 | 112 | 4 | int:LCP2 | |
| Interaction | ERG interactions | 2.50e-04 | 223 | 112 | 7 | int:ERG | |
| Interaction | NFIX interactions | 2.79e-04 | 227 | 112 | 7 | int:NFIX | |
| Interaction | KLF3 interactions | 2.87e-04 | 228 | 112 | 7 | int:KLF3 | |
| Interaction | NR3C1 interactions | ARHGAP32 FBRS NR4A3 POGZ NR4A1 POM121C TGFB1I1 PPARGC1A PHLDB1 ATXN7 MED25 ANKRD17 MAP2K2 CNOT1 FOXP3 | 3.21e-04 | 974 | 112 | 15 | int:NR3C1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | SHANK1 SPHK2 SIGLEC8 ZNF865 PRR12 BCL2L12 MAP4K1 MED25 SIX5 CCDC9 | 8.54e-04 | 1192 | 115 | 10 | chr19q13 |
| Cytoband | 9q21.32 | 1.03e-03 | 19 | 115 | 2 | 9q21.32 | |
| Cytoband | 19q13.3 | 1.17e-03 | 82 | 115 | 3 | 19q13.3 | |
| Cytoband | 7q36 | 2.10e-03 | 27 | 115 | 2 | 7q36 | |
| GeneFamily | Cas scaffolding proteins | 1.15e-04 | 4 | 80 | 2 | 469 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinase kinases | 1.92e-04 | 5 | 80 | 2 | 655 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF207 BCL11A RREB1 ZNF865 BCL11B EGR3 ZNF358 ZNF746 ZFHX2 ZNF598 GLIS1 | 3.10e-04 | 718 | 80 | 11 | 28 |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.96e-03 | 15 | 80 | 2 | 529 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | SHANK1 CACNA1A ERBB4 TCF7L2 ZFYVE27 WAS MAP1A POLR3GL ARHGAP17 POGZ BCL11A TTC3 SHROOM2 CDCA2 PPARGC1A FOXP4 CELSR1 SYNJ1 ZNF358 SCN8A ZFHX2 | 5.53e-06 | 1370 | 109 | 21 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_500 | 6.88e-06 | 137 | 109 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k2 | |
| CoexpressionAtlas | alpha beta T cells, T.4+8int.Th, 4+ 8int TCRhi, Thymus, avg-3 | 2.60e-05 | 302 | 109 | 9 | GSM399362_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.68e-05 | 243 | 109 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3 | |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.16e-05 | 123 | 109 | 6 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#1_top-relative-expression-ranked_100 | 5.75e-05 | 41 | 109 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_100_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_100 | 7.02e-05 | 16 | 109 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_100 | 7.69e-05 | 85 | 109 | 5 | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_100 | 1.12e-04 | 92 | 109 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#4 | 1.12e-04 | 92 | 109 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#1_top-relative-expression-ranked_100 | 1.59e-04 | 53 | 109 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_100_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.61e-04 | 157 | 109 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_200 | 1.71e-04 | 54 | 109 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.17e-04 | 166 | 109 | 6 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | REPS1 POLR3GL KIF26B CECR2 BCL11A PALB2 KRBA1 BCL11B ZFHX4 FYB1 | 2.24e-04 | 492 | 109 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_200 | 2.24e-04 | 167 | 109 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | SYNPO2 SETD1B TRIO EFS KIF26B BCL11A TNRC6C PPARGC1A FOXP4 CELSR1 ZFHX4 NFATC4 SIPA1L1 | 2.51e-04 | 806 | 109 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500 | 2.79e-04 | 25 | 109 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_k2_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4.Pa.BDC, 4+ 8- BDC+, Pancreas, avg-2 | 2.92e-04 | 328 | 109 | 8 | GSM605756_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4.PLN.BDC, 4+ 8- BDC+, Lymph Node, avg-3 | 3.44e-04 | 336 | 109 | 8 | GSM605758_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.88e-04 | 120 | 109 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_200 | 3.93e-04 | 28 | 109 | 3 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_200 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.75e-07 | 187 | 115 | 7 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.75e-07 | 187 | 115 | 7 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.75e-07 | 187 | 115 | 7 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.39e-07 | 190 | 115 | 7 | da7341a8a423e5fe4d8e733d8e50c10a3318ac1c | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.39e-07 | 190 | 115 | 7 | 42312f7d79fe889397d32910b625793e2535cc26 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.39e-07 | 190 | 115 | 7 | 682418a7a2096743112eae3790d40e7e600612c0 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 8.43e-07 | 198 | 115 | 7 | 6d12ecaa9532c134d9c4562534dcb59a6420b4d3 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like-IPs_and_early_cortical_neurons|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 8.43e-07 | 198 | 115 | 7 | 7943e4f67c3d6efb5c8b00aa0ff3cfe7be10c48d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.38e-06 | 184 | 115 | 6 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.19e-06 | 187 | 115 | 6 | 93c78fc7f126132eb84feb47be2c4e8c568b9e91 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.48e-06 | 188 | 115 | 6 | 1efbc99bcd6542e5d9fa91edb7c4295167914786 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.77e-06 | 189 | 115 | 6 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.77e-06 | 189 | 115 | 6 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | COVID_vent-Lymphocytic-B_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.01e-05 | 190 | 115 | 6 | 40b5e9e8f8fd8d84cb5b43e67b49267082348e9f | |
| ToppCell | COVID_vent-Lymphocytic-B_cell-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.01e-05 | 190 | 115 | 6 | a37a32dc1b931562a6660074e19d5598efc65284 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 190 | 115 | 6 | cc17ab84a9328124f146951c06be3eff9650d9fd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 191 | 115 | 6 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-05 | 193 | 115 | 6 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 1.24e-05 | 197 | 115 | 6 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 1.24e-05 | 197 | 115 | 6 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-B_intermediate|Influenza_Severe / Disease, condition lineage and cell class | 1.27e-05 | 198 | 115 | 6 | ab622fee61714471af3a7be0af356e8a484dcaff | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.84e-05 | 153 | 115 | 5 | ee6f4770c6e35d59bdeec5b0ecb10119fa8c3ca5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.84e-05 | 153 | 115 | 5 | a35149a0c8b4ec9ad27cc4b3d34fba3b8714a6a2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.84e-05 | 153 | 115 | 5 | 90cd6efda83c0b4b80eae2c90e7ff45dfd936dc2 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.98e-05 | 160 | 115 | 5 | 8a41e2c96e0e170ac35daf6c403bf961b8d7c30b | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.98e-05 | 160 | 115 | 5 | d6678996e12eaf2b735f1dfae32418cb2fabf268 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.98e-05 | 160 | 115 | 5 | c8dc575562b463fd30832d322c28006f18f7ab9c | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.72e-05 | 164 | 115 | 5 | cfe07a1ebed8aecb08d0476db71fe314998d54aa | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-plasmacytoid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.72e-05 | 164 | 115 | 5 | 6d331e74efecb4733d87653f86cd67247be05025 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.92e-05 | 165 | 115 | 5 | fead3f2032f8fa5f7f0159a4434989b3d65debbb | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.33e-05 | 167 | 115 | 5 | d80b64322d16d98c82a52724809740b9de208f39 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.33e-05 | 167 | 115 | 5 | f4943fb5001475ddab82a0273bcbb3fa68fdd7bd | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-05 | 167 | 115 | 5 | e228b8373ffd4436e6b944e26d0fadf3ac289b21 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-05 | 167 | 115 | 5 | 7cb1b11e8e24a10115e46ffbb74889e672a7a026 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-05 | 167 | 115 | 5 | bb53a478b5d821d6d82c15bc4ed075b67682457c | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D175|Adult / Lineage, Cell type, age group and donor | 7.53e-05 | 168 | 115 | 5 | 14071b961c9bdb54a8259b12a88237b802cbde36 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 168 | 115 | 5 | dc1143bd8db70c490167d73a525fd9b783eba960 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 168 | 115 | 5 | a75d63ae8ad64b5560853775f6df398feb314ce8 | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-05 | 169 | 115 | 5 | 700a3a36c379872585204caa6a6cc269b036ae22 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.19e-05 | 171 | 115 | 5 | a31c23406cf6d6a17358a8fb41d392a7fb0306e0 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.19e-05 | 171 | 115 | 5 | 43d8fd9b9546e84a652564fe96b514b34b06262b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.42e-05 | 172 | 115 | 5 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-regulatory_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.42e-05 | 172 | 115 | 5 | 425970e9ce8943f7e2ba6ca958e7a3a29baa798c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.42e-05 | 172 | 115 | 5 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.42e-05 | 172 | 115 | 5 | ca0cc0e92b6cdce5016f18fcb2ec1508cb222502 | |
| ToppCell | droplet-Fat-Mat-18m-Lymphocytic-lymphocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 172 | 115 | 5 | 226de1a5d4a360d3ae01b0235fea19521ec623a0 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-05 | 173 | 115 | 5 | 1b9b4e165121b08ef15a93fca6bea875cae69f19 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-05 | 173 | 115 | 5 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-05 | 173 | 115 | 5 | c25f24d7b672c9686d31ebc8d263042282f520fd | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-05 | 173 | 115 | 5 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.89e-05 | 174 | 115 | 5 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-05 | 175 | 115 | 5 | 21bc0e59a9509d38751ce6aad2325f341bc70eff | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.13e-05 | 175 | 115 | 5 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | facs-SCAT-Fat-24m-Lymphocytic-NK_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-05 | 175 | 115 | 5 | d82153bdb0c5cca96485d6b0579440f9c9e3abe2 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.38e-05 | 176 | 115 | 5 | 24b2e94ee5defcefb64a1f2447a2cc71b015b0fd | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.38e-05 | 176 | 115 | 5 | 29cda51a99100ddd2928cadc92da40f001d7e1f4 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.38e-05 | 176 | 115 | 5 | 01774a86d7d92f31a056b753f9844f923038003e | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.63e-05 | 177 | 115 | 5 | a235ff4f37a7622216526191efc4832fb8ed6957 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.63e-05 | 177 | 115 | 5 | f360f7099570d248531897b96e0de282e58f59e9 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.63e-05 | 177 | 115 | 5 | 9d2d70d53b919fed3328812889a55e5e1a0759de | |
| ToppCell | metastatic_Brain-Fibroblasts-Undetermined|metastatic_Brain / Location, Cell class and cell subclass | 9.63e-05 | 177 | 115 | 5 | 54f39be5d90363cfd44dea1a96ae06d3143aa795 | |
| ToppCell | COVID-19_Moderate-B_intermediate|COVID-19_Moderate / disease group, cell group and cell class | 9.63e-05 | 177 | 115 | 5 | 68e3d12a0c048a2d0f1b9680c7338a35855bba30 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-pDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.63e-05 | 177 | 115 | 5 | e36c2005be74ee8ff03c2052504cb496faf86009 | |
| ToppCell | IPF-Myeloid-pDC|IPF / Disease state, Lineage and Cell class | 9.89e-05 | 178 | 115 | 5 | 8d9e28492e1f157bac3308aa947fd864ca16d277 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 179 | 115 | 5 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 179 | 115 | 5 | dcaf2191134a586d50ebaf67dcf5b815b54a722b | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 179 | 115 | 5 | 87a69f9f83b8f0c028a4874acb238f2e079bf51f | |
| ToppCell | IPF-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 1.04e-04 | 180 | 115 | 5 | 0f8567aa835d4e3a52f6631ae15216eca18a030c | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 180 | 115 | 5 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 180 | 115 | 5 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | COVID-19_Moderate-B_intermediate|World / disease group, cell group and cell class | 1.04e-04 | 180 | 115 | 5 | bd81b87a6dc81e5ab4a6c948eb0c80f14401a6a7 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 180 | 115 | 5 | df60970520fba2ac0639faa54096766d07418ca4 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 180 | 115 | 5 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.04e-04 | 180 | 115 | 5 | d9dae9db8e17f6990032ee6cfa8393fae4768ca5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 181 | 115 | 5 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 181 | 115 | 5 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 182 | 115 | 5 | 37547b36264090b49a193a8ef3a8d88e647f0b79 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.10e-04 | 182 | 115 | 5 | 9ba85f621a846531a2a7861e9df695d288c9e149 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 183 | 115 | 5 | 6c4a09c02e30e1f24dde39f8cb8c5b453826ee2e | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.16e-04 | 184 | 115 | 5 | 3f8a359e40bebe58545f708682e5e5d1b70cf5cb | |
| ToppCell | Striatum-Macroglia|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.16e-04 | 184 | 115 | 5 | 9ed6a7c7171823b72561db9a6c1de47e82edc4c9 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.16e-04 | 184 | 115 | 5 | 64bede8db709fd32f40c03265b96f0b12155bb8a | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.19e-04 | 185 | 115 | 5 | 6bab4fc08bdc3de040bbcc750e1ee30932fcadbe | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.19e-04 | 185 | 115 | 5 | 609080adb2cfb105bb7b8efb617553833299f371 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-04 | 185 | 115 | 5 | 2df3e814859c8f468d203f9d84ecc02e0c5788ad | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.22e-04 | 186 | 115 | 5 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 186 | 115 | 5 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 186 | 115 | 5 | 37860daeecd6d412bd3797f30496a56da667fbd1 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 186 | 115 | 5 | 60830822d3de3147816693404fd03392e04c2b8e | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.22e-04 | 186 | 115 | 5 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | Mild_COVID-19-B_cell-B_cell|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.22e-04 | 186 | 115 | 5 | 855a5a00ba2aa1b5c63b8db56d026ddecc546050 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 186 | 115 | 5 | baebeffdd426ce767190ddefc857cc78e6a58d36 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 187 | 115 | 5 | 8fa454dc4e6a3e8e2bb2ad803acc579e0d3f76da | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 187 | 115 | 5 | 2b1b2c3792d6c9ab69675ce88842bb589414b530 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 187 | 115 | 5 | 5d3d68519c8e19f10c29f9d81712125be78ca15a | |
| ToppCell | metastatic_Brain-T/NK_cells-Treg|metastatic_Brain / Location, Cell class and cell subclass | 1.25e-04 | 187 | 115 | 5 | 1b88e1399809c50a0156096d9c82b1d9e58bb720 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 187 | 115 | 5 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | Control-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 1.25e-04 | 187 | 115 | 5 | 4e64be635f445276e71f2937f33f041c3a4204ab | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 187 | 115 | 5 | 5c73010fe4c85fb5cc1273f5504821229ca0cc4b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 187 | 115 | 5 | edad646d5eb1d70b768dc21fe02ef5265214e8e6 | |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; PC3; HG-U133A | 5.73e-06 | 194 | 113 | 8 | 1884_DN | |
| Drug | Dichlorphenamide [120-97-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 5.95e-06 | 195 | 113 | 8 | 3366_UP | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; PC3; HT_HG-U133A | 5.95e-06 | 195 | 113 | 8 | 4664_DN | |
| Drug | Gabazine [105538-73-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 6.18e-06 | 196 | 113 | 8 | 3253_UP | |
| Drug | Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; PC3; HT_HG-U133A | 6.91e-06 | 199 | 113 | 8 | 6624_DN | |
| Drug | Fenbendazole [43210-67-9]; Down 200; 13.4uM; PC3; HT_HG-U133A | 7.17e-06 | 200 | 113 | 8 | 4542_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 2.36e-05 | 171 | 113 | 7 | 7535_DN | |
| Drug | Calcimycin | 5.15e-05 | 132 | 113 | 6 | ctd:D000001 | |
| Drug | Megestrol acetate [595-33-5]; Down 200; 10.4uM; PC3; HT_HG-U133A | 5.28e-05 | 194 | 113 | 7 | 6667_DN | |
| Drug | 17-AAG; Down 200; 1uM; SKMEL5; HG-U133A | 5.45e-05 | 195 | 113 | 7 | 505_DN | |
| Drug | Pizotifen malate [5189-11-7]; Down 200; 9.4uM; HL60; HT_HG-U133A | 5.63e-05 | 196 | 113 | 7 | 3134_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 5.63e-05 | 196 | 113 | 7 | 1628_DN | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; PC3; HT_HG-U133A | 5.81e-05 | 197 | 113 | 7 | 3685_UP | |
| Drug | CP-863187 [668981-07-5]; Down 200; 10uM; PC3; HT_HG-U133A | 5.81e-05 | 197 | 113 | 7 | 7512_DN | |
| Drug | Sulfaquinoxaline sodium salt [967-80-6]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 5.81e-05 | 197 | 113 | 7 | 6788_DN | |
| Drug | STOCK1N-35874; Down 200; 14uM; PC3; HT_HG-U133A | 5.81e-05 | 197 | 113 | 7 | 6583_DN | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 5.81e-05 | 197 | 113 | 7 | 2654_UP | |
| Drug | Myosmine [532-12-7]; Up 200; 27.4uM; PC3; HT_HG-U133A | 5.81e-05 | 197 | 113 | 7 | 3737_UP | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 5.81e-05 | 197 | 113 | 7 | 6497_UP | |
| Drug | Naproxen [22204-53-1]; Up 200; 17.4uM; PC3; HT_HG-U133A | 5.81e-05 | 197 | 113 | 7 | 1828_UP | |
| Drug | Cisapride [81098-60-4]; Up 200; 8.6uM; PC3; HT_HG-U133A | 6.00e-05 | 198 | 113 | 7 | 6706_UP | |
| Drug | Bufexamac [2438-72-4]; Up 200; 18uM; MCF7; HT_HG-U133A | 6.00e-05 | 198 | 113 | 7 | 5515_UP | |
| Drug | Norfloxacin [70458-96-7]; Up 200; 12.6uM; PC3; HT_HG-U133A | 6.00e-05 | 198 | 113 | 7 | 2090_UP | |
| Drug | Dirithromycin [62013-04-1]; Up 200; 4.8uM; HL60; HG-U133A | 6.00e-05 | 198 | 113 | 7 | 1712_UP | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; HL60; HT_HG-U133A | 6.00e-05 | 198 | 113 | 7 | 2724_DN | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; HL60; HT_HG-U133A | 6.00e-05 | 198 | 113 | 7 | 1184_DN | |
| Drug | Niacin [59-67-6]; Up 200; 32.4uM; MCF7; HT_HG-U133A | 6.00e-05 | 198 | 113 | 7 | 3381_UP | |
| Drug | (+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; MCF7; HT_HG-U133A | 6.00e-05 | 198 | 113 | 7 | 5469_DN | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; PC3; HT_HG-U133A | 6.20e-05 | 199 | 113 | 7 | 7295_DN | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A | 6.20e-05 | 199 | 113 | 7 | 2057_DN | |
| Drug | sulfachloropyridazine | 9.20e-05 | 18 | 113 | 3 | CID000006634 | |
| Disease | Tremor, Rubral | 2.72e-05 | 16 | 110 | 3 | C0750940 | |
| Disease | Ataxia, Appendicular | 2.72e-05 | 16 | 110 | 3 | C0750937 | |
| Disease | Ataxia, Motor | 2.72e-05 | 16 | 110 | 3 | C0278161 | |
| Disease | Ataxia, Sensory | 2.72e-05 | 16 | 110 | 3 | C0240991 | |
| Disease | Abnormal coordination | 2.72e-05 | 16 | 110 | 3 | C0520966 | |
| Disease | Ataxia, Truncal | 2.72e-05 | 16 | 110 | 3 | C0427190 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 4.72e-05 | 105 | 110 | 5 | DOID:9352 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | 7.67e-05 | 477 | 110 | 9 | C0005586 | |
| Disease | specific developmental disorder (implicated_via_orthology) | 8.22e-05 | 4 | 110 | 2 | DOID:0060038 (implicated_via_orthology) | |
| Disease | Wiskott-Aldrich syndrome (implicated_via_orthology) | 8.22e-05 | 4 | 110 | 2 | DOID:9169 (implicated_via_orthology) | |
| Disease | age at first birth measurement | 8.91e-05 | 120 | 110 | 5 | EFO_0009101 | |
| Disease | Ataxia | 1.09e-04 | 25 | 110 | 3 | C0004134 | |
| Disease | bronchiolitis obliterans (biomarker_via_orthology) | 2.05e-04 | 6 | 110 | 2 | DOID:2799 (biomarker_via_orthology) | |
| Disease | Spinocerebellar Ataxia Type 2 | 2.77e-04 | 34 | 110 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 2.77e-04 | 34 | 110 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 2.77e-04 | 34 | 110 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 2.77e-04 | 34 | 110 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 2.77e-04 | 34 | 110 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 2.77e-04 | 34 | 110 | 3 | C0087012 | |
| Disease | blood urea nitrogen measurement | 2.99e-04 | 452 | 110 | 8 | EFO_0004741 | |
| Disease | Spinocerebellar Ataxia Type 4 | 3.02e-04 | 35 | 110 | 3 | C0752122 | |
| Disease | Neurodevelopmental Disorders | 4.14e-04 | 93 | 110 | 4 | C1535926 | |
| Disease | ciliopathy (implicated_via_orthology) | 4.50e-04 | 40 | 110 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | uric acid measurement | ERBB4 TCF7L2 ARHGAP17 RREB1 LARP4B RGS20 MAP4K5 ARHGEF26 GLIS1 | 4.74e-04 | 610 | 110 | 9 | EFO_0004761 |
| Disease | asthma, sex interaction measurement | 4.87e-04 | 9 | 110 | 2 | EFO_0008343, MONDO_0004979 | |
| Disease | RASopathy (implicated_via_orthology) | 4.87e-04 | 9 | 110 | 2 | DOID:0080690 (implicated_via_orthology) | |
| Disease | migraine (is_implicated_in) | 4.87e-04 | 9 | 110 | 2 | DOID:6364 (is_implicated_in) | |
| Disease | occupational attainment | 5.21e-04 | 42 | 110 | 3 | EFO_0020977 | |
| Disease | urate measurement, bone density | ERBB4 TCF7L2 RAP1GAP2 PPARGC1A LARP4B BCL11B CLEC17A MAP4K5 TNXB | 5.26e-04 | 619 | 110 | 9 | EFO_0003923, EFO_0004531 |
| Disease | QRS-T angle | 6.78e-04 | 106 | 110 | 4 | EFO_0020097 | |
| Disease | level of Diacylglycerol (18:1_18:1) in blood serum | 7.41e-04 | 11 | 110 | 2 | OBA_2045170 | |
| Disease | birth weight, parental genotype effect measurement | 7.80e-04 | 192 | 110 | 5 | EFO_0004344, EFO_0005939 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 8.36e-04 | 195 | 110 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | nicotine dependence (implicated_via_orthology) | 8.87e-04 | 12 | 110 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | QRS duration | 8.98e-04 | 298 | 110 | 6 | EFO_0005055 | |
| Disease | body mass index, fasting blood glucose measurement | 9.22e-04 | 51 | 110 | 3 | EFO_0004340, EFO_0004465 | |
| Disease | obesity (implicated_via_orthology) | 1.29e-03 | 215 | 110 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | cigarettes per day measurement | 1.30e-03 | 438 | 110 | 7 | EFO_0006525 | |
| Disease | cardiac troponin T measurement | 1.40e-03 | 219 | 110 | 5 | EFO_0005043 | |
| Disease | Insulin Resistance | 1.48e-03 | 60 | 110 | 3 | C0021655 | |
| Disease | Insulin Sensitivity | 1.48e-03 | 60 | 110 | 3 | C0920563 | |
| Disease | leptin measurement, type 2 diabetes mellitus | 1.60e-03 | 16 | 110 | 2 | EFO_0005000, MONDO_0005148 | |
| Disease | Huntington's disease (biomarker_via_orthology) | 1.60e-03 | 16 | 110 | 2 | DOID:12858 (biomarker_via_orthology) | |
| Disease | diabetic retinopathy (implicated_via_orthology) | 1.60e-03 | 16 | 110 | 2 | DOID:8947 (implicated_via_orthology) | |
| Disease | sickle cell anemia (is_implicated_in) | 1.60e-03 | 16 | 110 | 2 | DOID:10923 (is_implicated_in) | |
| Disease | respiratory symptom change measurement, response to placebo | 1.81e-03 | 17 | 110 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | neutrophil count | CACNA1A SPHK2 POLR3GL POGZ RREB1 BCL11B ATXN7 MAP4K5 SH3D19 B4GALNT2 AGBL2 TNXB CCDC9 | 1.92e-03 | 1382 | 110 | 13 | EFO_0004833 |
| Disease | cognitive function measurement, self reported educational attainment | 2.18e-03 | 355 | 110 | 6 | EFO_0004784, EFO_0008354 | |
| Disease | fasting blood insulin measurement | 2.21e-03 | 69 | 110 | 3 | EFO_0004466 | |
| Disease | Malignant neoplasm of breast | ERBB4 BCL11A BCAR1 TTC3 SHROOM2 PALB2 FOXP4 STPG1 SIPA1L1 NOS3 FOXP3 | 2.26e-03 | 1074 | 110 | 11 | C0006142 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.56e-03 | 152 | 110 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Drugs used in diabetes use measurement | 2.72e-03 | 255 | 110 | 5 | EFO_0009924 | |
| Disease | social deprivation, COVID-19 | 2.76e-03 | 21 | 110 | 2 | EFO_0009696, MONDO_0100096 | |
| Disease | epilepsy (implicated_via_orthology) | 3.29e-03 | 163 | 110 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | gestational diabetes | 3.31e-03 | 23 | 110 | 2 | EFO_0004593 | |
| Disease | BMI-adjusted fasting blood glucose measurement | 3.31e-03 | 23 | 110 | 2 | EFO_0008036 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 3.36e-03 | 80 | 110 | 3 | DOID:1459 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSNPGPPKTPENSLI | 1131 | O00555 | |
| SEFSLKPGTVLPPPP | 1286 | Q15303 | |
| LAPLPLPSPTSPGFQ | 91 | Q96L91 | |
| VLAPQPGPGPPFTLK | 316 | Q8NCV1 | |
| SPSKPFGPQELAKPP | 226 | Q5JRM2 | |
| VFSSPKPELPSPAPG | 96 | Q8NHY0 | |
| PLPSPPKFTSQDSPD | 636 | P56945 | |
| DSSPGKLDPAPSQPP | 1291 | Q9UIF9 | |
| GPKPFSAPKPQTSPS | 296 | Q01518 | |
| PSPLEGLSFSPFPPS | 86 | Q8N1L1 | |
| KSPPSPELQGPPSTE | 191 | Q9HB09 | |
| KSPANGAVTLPAPPP | 126 | Q96DR7 | |
| SAGPKNPAPTPDFPF | 616 | Q9NYQ6 | |
| PANKPIAPNFSAPLP | 2236 | O75179 | |
| LQPPPVPAPSSLFGA | 871 | Q9BXF3 | |
| PASQPPPPRSLFSDK | 1246 | Q9BXF3 | |
| LPANTPSPSFSKLPP | 536 | Q5T6C5 | |
| PGEFLTPPTPPITFL | 111 | Q5T5A4 | |
| VNEPPPKLPNGVFTP | 326 | P36507 | |
| KSPRPAGPQLFLPDP | 151 | Q9BUH6 | |
| QLPKASGPPQPPAFF | 176 | P22736 | |
| FSPPLTALPTAPPGL | 331 | P57723 | |
| PETSPSFLPPLPSLG | 226 | A5PL33 | |
| GELSPSFLNPPLPPS | 2446 | P78559 | |
| PGKPSAPSLALGPSP | 6 | Q9BZS1 | |
| GVLPSPAPLPPSSKD | 1096 | Q2KJY2 | |
| SPTPPKPPSPSFELG | 516 | Q92615 | |
| FQPGSKPPFLATPPL | 346 | Q9H165 | |
| GPAPPTTFKPNSPDL | 921 | Q9HC56 | |
| FPQLLPKTSPQSAPP | 476 | Q6ZU69 | |
| FPQLLPKTSPQSAPP | 206 | Q63HN1 | |
| PSNVPKFGSPKPPVA | 51 | O15117 | |
| SKQPVPLPPAAPSGA | 241 | Q71SY5 | |
| EPKPFSQPLNPVPGS | 376 | Q8IVH2 | |
| LQPPTEPGLPPTFTF | 221 | Q68DD2 | |
| TPPNLPSDKIYPPSG | 1236 | A7KAX9 | |
| PASPGPQGPSTKLPL | 571 | Q3MIN7 | |
| NCPSIPKPTLPSPGQ | 291 | O15265 | |
| SSPLTQPPEGPKFPR | 56 | P29474 | |
| GPPASVPLPAPFFKQ | 756 | A8CG34 | |
| KSPAFTAVPLSDPPP | 526 | Q0D2I5 | |
| PLTPESPNDPKGSPF | 261 | Q9UBK2 | |
| PPGTPPPIESFTFKE | 806 | Q86YC2 | |
| PVPTFQKVPLPSGPA | 556 | P81408 | |
| QPKSTNPELPPRLGP | 46 | Q9HAH7 | |
| QPSPKSPFLSTPPLP | 396 | Q9C0K0 | |
| PSAPAPSKPFLLSTP | 131 | Q6ZNG2 | |
| PLLEPQAPGTPSSPF | 476 | Q9Y3X0 | |
| PGFGSLPQPPLTLKP | 241 | Q06889 | |
| PGSSFNFRKAPPPIP | 531 | O95886 | |
| NFRKAPPPIPPGSQA | 536 | O95886 | |
| PPGFPPIQGLEATKP | 406 | Q6P1N0 | |
| SLQPPPPRFKDSPAS | 111 | Q5U5Z8 | |
| LPAGPAPKPSLSPAS | 66 | O43281 | |
| APKPSLSPASPAQPG | 71 | O43281 | |
| PKPLPDRPTLAAFSP | 1301 | O60336 | |
| LPPNPCTPDTFKSPL | 41 | Q69YH5 | |
| RDPIFQPPSPPKGLL | 531 | Q05932 | |
| APPVAGPSVFLFPPK | 111 | P01859 | |
| LKGLGPPPLPPSSQS | 466 | Q8NBF1 | |
| RDFPKPAINGLPPTP | 476 | Q9Y4K4 | |
| SAGLSKPFPPPNIPI | 346 | A6NHN0 | |
| PLPPKPKFRSPSDEG | 396 | Q92918 | |
| AAPLAFPPLGLTPSP | 251 | Q92570 | |
| KTVFLSGLPPPPAEP | 111 | Q9NP92 | |
| KGDALPPPTLQPSPL | 26 | Q9BT43 | |
| EEPTPSPFLPSPSLK | 1026 | Q9HCJ0 | |
| TFGPPLPSPPVFQKG | 411 | Q684P5 | |
| PANVSKGTTPLAPPP | 686 | Q96D71 | |
| PLKSPVPFLPGTSPS | 381 | A5PKW4 | |
| PPKGFTPPPLRDSTL | 226 | B4DYI2 | |
| PPPLPAEKPIGNTFS | 276 | Q5HYK7 | |
| LKPQAAFPPQSSLPP | 1241 | O43426 | |
| YSDSTNPGPPKTPPI | 131 | P04053 | |
| LPASPPLEGPFPSQS | 816 | Q14934 | |
| PSTPPLGKQNPSLPA | 761 | Q68EM7 | |
| SFPPAQLPDSPAAPK | 56 | O76081 | |
| APPLPGPIKFPAGVS | 21 | Q5VWT5 | |
| TTNPKLAPSFPSPPA | 281 | Q7Z3K3 | |
| VPSFGPPIPKGVTFP | 761 | O43166 | |
| FSPDSPGLLPNFPAP | 636 | Q8N196 | |
| NPLKKPPPAVAPSSG | 426 | Q9NYZ4 | |
| FPPPPFGLPIASLAE | 241 | O15266 | |
| PPSQKAPNPPTFSEL | 981 | Q13796 | |
| KSLAQPQSPFPALPP | 576 | Q6ZUB0 | |
| TPPPAQATPAPGFKS | 381 | Q9UPS6 | |
| LGAFLQKSPPPPPPT | 756 | Q9ULL5 | |
| PLPPPLEFSNSFEKP | 1566 | Q9Y566 | |
| PPQQAGSPLKRPFPA | 481 | P0C7V6 | |
| STPPYKDLPPKPGSS | 81 | Q6ZS10 | |
| TPQSPAKAFPPLSTP | 746 | A5YKK6 | |
| KSLAQPQSPFPALPP | 576 | P0C874 | |
| PPPSYPNLKIPGLNS | 641 | Q13435 | |
| SDPSPPSQGTKPALP | 2371 | Q86UP3 | |
| SSQAKKPDPPLPPAF | 116 | P0CJ78 | |
| GPQPFLPPGKEATTP | 1976 | Q9C0A1 | |
| PTQPPAFPTSNPSKG | 786 | Q9UMS6 | |
| SPDPLLSSPPGSPKA | 466 | Q9NRA0 | |
| PPQISLPPFSKAPAA | 481 | Q92766 | |
| LNFSAQPSPLPPKPP | 251 | Q5TH74 | |
| PQDPSLEASGPSPKP | 746 | Q8IX01 | |
| AKILPQSDPSPGTPP | 1146 | P22105 | |
| PPSPNLLGSPPRDAK | 511 | Q9NQB0 | |
| PSPPSGLLPATVQPF | 66 | Q9Y5U2 | |
| KTPGAPESSALQPPP | 446 | P42768 | |
| PEFSPPSSQPPKHKG | 426 | P53804 | |
| LAPPGPDSFKPFTPE | 6 | Q9UQD0 | |
| TSIPGSPKFQPPVPA | 376 | Q86UU1 | |
| PGPLSLPSPESQFSP | 386 | A2A288 | |
| LPSPESQFSPGDLPP | 391 | A2A288 | |
| PISKPPPGFSGLLPS | 706 | Q86UK7 | |
| PQPPVTKPLFPSAGQ | 246 | O43670 | |
| APLESPPFPTKSPAF | 21 | Q5T4F4 | |
| SFGKPDPLPTVLPAP | 176 | A8MUI8 | |
| PSLPSSPSPGLPKAS | 136 | O43294 | |
| DPTKPPSLAPGTTQP | 206 | Q9BZM6 | |
| TLPPPFNIIPSPKSF | 656 | Q9UL62 | |
| APPDPFKSPASKGPL | 606 | Q6NUN9 | |
| KSPSRLSPAQGPPQP | 271 | A4D1P6 | |
| PSLGKEPFPPSSPLQ | 2466 | O75962 | |
| LPPPFSLVPSPKSFV | 691 | Q13507 | |
| SGPGTLPDPSSKPLP | 466 | Q9NW07 | |
| PTPSVVNLPFPKEGP | 886 | E9PAV3 | |
| VNLPFPKEGPATPAP | 891 | E9PAV3 |